Boosted atazanavir and Truvada [tenofovir disoproxil fumarate + emtricitabine] given once-daily (BATON study): A phase 4 study of safety, efficacy and adherence in HIV infected, antiretroviral naive subjects treated with a simple once-daily regimen
Phase of Trial: Phase IV
Latest Information Update: 09 Jan 2013
At a glance
- Drugs Atazanavir (Primary) ; Emtricitabine (Primary) ; Ritonavir; Tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms BATON
- 07 Jun 2017 Biomarkers information updated
- 04 Dec 2007 Status changed from in progress to completed.
- 19 Nov 2005 New trial record.